1416 Results

People

  1. Motzer
    Motzer
  2. Vickers
    Vickers
  3. Hudis
    Hudis
  4. Norton
    Norton
  5. Saltz
    Saltz
  6. O'Reilly
    O'Reilly
  7. Mao
    Mao
  8. Morris
    Morris
  9. Seidman
    Seidman
  10. Kris
    Kris

Groups

  1. Department of Medicine (753)
  2. Solid Tumor Oncology Division (541)
  3. Population Sciences Research Program (259)
  4. Survivorship Research (256)
  5. Surgery (244)
  6. Epidemiology and Biostatistics (187)
  7. Hematologic Malignancies, Division of (169)
  8. Genitourinary Oncology Service (160)
  9. Center for Hematologic Malignancies (142)
  10. Gastrointestinal Oncology Service (126)
  1. "randomized controlled trial"
Formats
  1. Journal Article (1353)
  2. Review (19)
  3. Conference Paper (17)
  4. Editorial (9)
  5. Correspondence (5)
  6. Research Letter (5)
  7. Meeting Abstract (4)
  8. Guidelines (3)
  9. Book Section (1)
Groups
  1. Department of Medicine (753)
  2. Solid Tumor Oncology Division (541)
  3. Population Sciences Research Program (259)
  4. Survivorship Research (256)
  5. Surgery (244)
  6. Epidemiology and Biostatistics (187)

More Groups

People
  1. Robert Motzer (83)
  2. Andrew Vickers (48)
  3. Larry Norton (34)
  4. Clifford Hudis (33)
  5. Leonard Saltz (32)
  6. Eileen O'Reilly (25)

More People

Years
  1. 2025 (63)
  2. 2024 (165)
  3. 2023 (110)
  4. 2022 (81)
  5. 2021 (39)
  6. 2020 (51)

More Years

Publications
  1. Journal of Clinical Oncology (164)
  2. New England Journal of Medicine (65)
  3. Lancet Oncology (46)
  4. Cancer (42)
  5. Clinical Cancer Research (42)
  6. European Urology (26)

More Publications

Publishers
  1. Elsevier Inc. (187)
  2. American Society of Clinical Oncology (170)
  3. Elsevier Science, Inc. (138)
  4. Springer (79)
  5. Lippincott Williams & Wilkins (72)
  6. Wiley Blackwell (71)

More Publishers

Results (1416)


Citation style sort is year ascending, and then by author or title. Author ascending is default.
  • Randomized phase III trial of ganitumab with interval-compressed chemotherapy for patients with newly diagnosed metastatic Ewing sarcoma: A report from the Children's Oncology Group
    Journal Article

    DuBois, S. G.; Krailo, M. D.; Glade-Bender, J.; Buxton, A.; Laack, N.; Randall, R. L.; Chen, H. X.; Seibel, N. L.; Boron, M.; Terezakis, S.; more...
    Journal of Clinical Oncology (2023)

    Fulltext@MSK | Save
  • Overall survival and updated results for sunitinib compared with interferon alfa in patients with metastatic renal cell carcinoma
    Journal Article

    Motzer, R. J.; Hutson, T. E.; Tomczak, P.; Michaelson, M. D.; Bukowski, R. M.; Oudard, S.; Negrier, S.; Szczylik, C.; Pili, R.; Bjarnason, G. A.; more...
    Journal of Clinical Oncology (2023)

    Fulltext@MSK | Save
  • Study protocol for a prospective, multi-centered randomized controlled trial comparing pelvic fascia-sparing radical prostatectomy with conventional robotic-assisted prostatectomy: The PARTIAL trial
    Journal Article

    Stangl-Kremser, J.; Kowalczyk, K.; Schaeffer, E. M.; Allaf, M.; Scherr, D.; Yang, X.; Matoso, A.; Azumi, N.; Robinson, B.; Vickers, A.; more...
    Contemporary Clinical Trials (2023)

    Fulltext@MSK | Save
  • Stem cell mobilization yields with daratumumab- and lenalidomide-containing quadruplet induction therapy in newly diagnosed multiple myeloma: Findings from the MASTER and GRIFFIN trials
    Journal Article

    Chhabra, S.; Callander, N.; Watts, N. L.; Costa, L. J.; Thapa, B.; Kaufman, J. L.; Laubach, J.; Sborov, D. W.; Reeves, B.; Rodriguez, C.; more...
    Transplantation and Cellular Therapy (2023)

    Fulltext@MSK | Save
  • Asciminib vs bosutinib in chronic-phase chronic myeloid leukemia previously treated with at least two tyrosine kinase inhibitors: Longer-term follow-up of ASCEMBL
    Journal Article

    Hochhaus, A.; Réa, D.; Boquimpani, C.; Minami, Y.; Cortes, J. E.; Hughes, T. P.; Apperley, J. F.; Lomaia, E.; Voloshin, S.; Turkina, A.; more...
    Leukemia (2023)

    Fulltext@MSK | Save
  • Current evidence does not support Mohs micrographic surgery or staged excision as equivalent to wide excision for primary cutaneous melanoma
    Editorial

    Huerta, T.; Swetter, S. M.; Nehal, K. S.; Coit, D. G.; Bichakjian, C. K.; Durham, A. B.
    Journal of the American Academy of Dermatology (2023)

    Fulltext@MSK | Save
  • Effects of a patient question prompt list on question asking and self-efficacy during outpatient palliative care appointments
    Journal Article

    McDarby, M.; Silverstein, H. I.; Carpenter, B. D.
    Journal of Pain and Symptom Management (2023)

    Fulltext@MSK | Save
  • A healthy lifestyle in men at increased genetic risk for prostate cancer
    Journal Article

    Plym, A.; Zhang, Y.; Stopsack, K. H.; Delcoigne, B.; Wiklund, F.; Haiman, C.; Kenfield, S. A.; Kibel, A. S.; Giovannucci, E.; Penney, K. L.; more...
    European Urology (2023)

    Fulltext@MSK | Save
  • Japanese subgroup analysis of EV-301: An open-label, randomized phase 3 study to evaluate enfortumab vedotin versus chemotherapy in subjects with previously treated locally advanced or metastatic urothelial carcinoma
    Journal Article

    Matsubara, N.; Yonese, J.; Kojima, T.; Azuma, H.; Matsumoto, H.; Powles, T.; Rosenberg, J. E.; Petrylak, D. P.; Matsangou, M.; Wu, C.; more...
    Cancer Medicine (2023)

    Fulltext@MSK | Save
  • Pembrolizumab in Asian patients with microsatellite-instability-high/mismatch-repair-deficient colorectal cancer
    Journal Article

    Yoshino, T.; Andre, T.; Kim, T. W.; Yong, W. P.; Shiu, K. K.; Jensen, B. V.; Jensen, L. H.; Punt, C. J. A.; Smith, D.; Garcia-Carbonero, R.; more...
    Cancer Science (2023)

    Fulltext@MSK | Save